erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Chorioamnionitis D002821 5 associated lipids
Obstetric Labor, Premature D007752 9 associated lipids
Hearing Disorders D006311 10 associated lipids
Duodenitis D004382 4 associated lipids
Death, Sudden D003645 12 associated lipids
Cardiomegaly D006332 31 associated lipids
Tachycardia D013610 7 associated lipids
Common Cold D003139 2 associated lipids
Hemoglobin SC Disease D006450 2 associated lipids
Foot Diseases D005534 4 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Kawasaki S et al. [Effects of a steroid and macrolide antibiotic on IL-8 production by neutrophils]. 1997 Jpn J Antibiot pmid:9597446
Mineshita M et al. [Effect of macrolide antibiotics on actin polymerization reactions of neutrophils]. 1997 Jpn J Antibiot pmid:9597447
Sato K et al. [Pyocyanine synthesis by Pseudomonas aeruginosa in chronic airway infection and the effect of erythromycin on its biological activity]. 1997 Jpn J Antibiot pmid:9597453
Ohara K et al. [Effects of pretreatment by erythromycin or rokitamycin on aminoglycoside inactivating enzyme of Pseudomonas aeruginosa]. 1997 Jpn J Antibiot pmid:9597454
Kobayashi O et al. [Actions of macrolide antibiotics on alginate production by Pseudomonas aeruginosa]. 1997 Jpn J Antibiot pmid:9597455
Kondo K et al. [Quantitative evaluation of the inhibitory action of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa]. 1997 Jpn J Antibiot pmid:9597456
Kudo S [Preliminary survey on DPB (diffuse panbronchitis) in Japan and a survey on the status of DPB in China]. 1997 Jpn J Antibiot pmid:9597457
Tei A et al. [Effects and actions of EM (erythromycin), CAM (clarithromycin), and JM (josamycin) on IL-4 and IL-5 production by monocytes]. 1997 Jpn J Antibiot pmid:9597458
Hoshina S et al. [C kinase activation and induction of HL 60 promyelocytic leukemia cell differentiation caused by roxithromycin]. 1997 Jpn J Antibiot pmid:9597464
Takada T et al. [Study of specific mRNA expression by peripheral monocytes of patients with diffuse panbronchitis using cDNA representational difference analysis (RDA)]. 1997 Jpn J Antibiot pmid:9597465
Kaseta M et al. [Study of therapeutic effects of macrolide antibiotics on patients with anti-HTLV-1 antibody positive DPB (diffuse panbronchitis)]. 1997 Jpn J Antibiot pmid:9597466
Miyashima S et al. [Effects of erythromycin on a mouse hypersensitivity pneumonia model]. 1997 Jpn J Antibiot pmid:9597469
Nonaka M et al. [Effects of macrolide antibiotics on fibroblasts]. 1997 Jpn J Antibiot pmid:9597470
Hori S et al. [Effects of macrolide drugs on endogenous glucocorticoids]. 1997 Jpn J Antibiot pmid:9597471
Hikariyama T et al. [Study of suppression of neutrophil functions and prevention of vascular endothelial injury by macrolide antibiotics]. 1998 Jpn J Antibiot pmid:9597473
Tamaoki J et al. [Effects of macrolide antibiotics on iNOS gene expression and NO production by alveolar macrophages]. 1998 Jpn J Antibiot pmid:9597474
Takeda H et al. [Bone absorption suppression by broad spectrum antibiotics]. 1998 Jpn J Antibiot pmid:9597475
Kawasaki S et al. [Effects of a steroid and macrolide antibiotic on adhesion of neutrophils to the airway epithelial cells]. 1998 Jpn J Antibiot pmid:9597483
Nakada K et al. [Therapeutic guideline for diffuse panbronchitis (draft). Subcommittee on Diffuse Lung Diseases, Research Committee on Respiratory Diseases Organized by the Ministry of Health and Welfare]. 1998 Jpn J Antibiot pmid:9597494
Shirai R et al. [Evaluation of the duration of medication with erythromycin for treatment of diffuse panbronchitis--a comparison between interruption of medication and continued administration]. 1998 Jpn J Antibiot pmid:9597496
Kishi K et al. [Study of efficacy of macrolide therapy applied to Kartagener's syndrome]. 1998 Jpn J Antibiot pmid:9597497
Miyazawa T et al. [Mucous pathology and macrolide treatment of paranasal sinusitis in children]. 1998 Jpn J Antibiot pmid:9597499
Okura M et al. [Multicenter study on clinical effects of a small dose of erythromycin on chronic lung disorders of premature infants--single blind comparison of treated and untreated groups. A committee for the Study of EM Therapy for Chronic Lung Diseases of Premature Infants]. 1998 Jpn J Antibiot pmid:9597500
Nishimura J et al. [Effects of erythromycin on Pseudomonas aeruginosa pyocyanine-induced IL-8 production and its biological activity (the 2nd report)]. 1998 Jpn J Antibiot pmid:9597503
Abe S et al. [Effect of macrolides on IL-8 gene expression by cultured airway epithelial cells]. 1998 Jpn J Antibiot pmid:9597504
Sugiyama Y et al. [Changes in cytokine production by pulmonary alveolar macrophages collected from rats that have been treated with erythromycin for an extended period]. 1998 Jpn J Antibiot pmid:9597506
Yoshimine H et al. [Inhibition of neutrophil-derived IL-8 production caused by EM (erythromycin) 201 derivative: modification of the activities by the 5-position desosamine side chain]. 1998 Jpn J Antibiot pmid:9597508
Kozeki S et al. [Study on bacterial biofilm destruction by various antibacterial agents]. 1998 Jpn J Antibiot pmid:9597510
Nakada M et al. [Inhibitory effects of macrolide antibiotics at low concentrations on vero toxin production by pathogenic E. coli O157]. 1998 Jpn J Antibiot pmid:9597511
Kyo S et al. [Effects of macrolides on intracellular Ca2+ response by airway epithelium]. 1998 Jpn J Antibiot pmid:9597513
Tanabe O et al. [Mechanism of erythromycin action on gene expression of airway epithelial cells]. 1998 Jpn J Antibiot pmid:9597514
Muranaka H et al. [Superoxide radical scavenging activity of an erythromycin-iron complex (the second report)]. 1998 Jpn J Antibiot pmid:9597516
Ng P et al. Diffuse panbronchiolitis: case report and review of the literature. 1998 Australas Radiol pmid:9599832
Karrer S et al. [Acne comedonica following radiation therapy]. 1998 Dtsch. Med. Wochenschr. pmid:9601475
Farrell AM et al. Pyoderma gangrenosum of the penis. 1998 Br. J. Dermatol. pmid:9602887
Vachálková A and Novotný L Polarographic testing of carcinogenicity of some chemotherapeutics. 1997 Neoplasma pmid:9605013
Paesen J et al. Study of the stability of erythromycin in a hydrophilic creme basis by liquid chromatography. 1998 J Pharm Biomed Anal pmid:9608426
Kudoh S Erythromycin treatment in diffuse panbronchiolitis. 1998 Curr Opin Pulm Med pmid:9612675
Neubrand M and Sauerbruch T Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid. 1998 Z Gastroenterol pmid:9612923
Gaisser S et al. Analysis of eryBI, eryBIII and eryBVII from the erythromycin biosynthetic gene cluster in Saccharopolyspora erythraea. 1998 Mol. Gen. Genet. pmid:9613575
Mathis C and Malbert CH Changes in pyloric resistance induced by erythromycin. 1998 Neurogastroenterol. Motil. pmid:9614671
Bourrat E et al. [Rosacea with ocular involvement in a child]. 1996 Ann Dermatol Venereol pmid:9615130
Syphilis--recommended treatment schedules, 1976. 1976 Am Fam Physician pmid:961559
Krone LV The importance of multiple antibiotic coverage for hospitalized patients when the community acquired pneumonia is Legionnaire's disease. 1998 WMJ pmid:9617308
Kudoh S et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. 1998 Am. J. Respir. Crit. Care Med. pmid:9620913
Kruppa A et al. Immediate reaction to roxithromycin and prick test cross-sensitization to erythromycin and clarithromycin. 1998 Dermatology (Basel) pmid:9621142
Widdowson CA and Klugman KP Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. 1998 Apr-Jun Emerging Infect. Dis. pmid:9621199
Rosato A et al. A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. 1998 Antimicrob. Agents Chemother. pmid:9624482
Muli F and Struthers JK Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus. 1998 Antimicrob. Agents Chemother. pmid:9624489
Kataja J et al. Different erythromycin resistance mechanisms in group C and group G streptococci. 1998 Antimicrob. Agents Chemother. pmid:9624500
Reinert RR et al. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. 1998 Antimicrob. Agents Chemother. pmid:9624505
Roblin PM and Hammerschlag MR In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. 1998 Antimicrob. Agents Chemother. pmid:9624507
Souli M et al. In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens. 1998 Int. J. Antimicrob. Agents pmid:9624540
Wirsing von König CH et al. Factors influencing the spread of pertussis in households. 1998 Eur. J. Pediatr. pmid:9625336
Wandel C et al. Effect of CYP3A inhibition on vesnarinone metabolism in humans. 1998 Clin. Pharmacol. Ther. pmid:9630823
Stassi DL et al. Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9636144
Novaes AB et al. Immediate implants placed into infected sites: a histomorphometric study in dogs. 1998 May-Jun Int J Oral Maxillofac Implants pmid:9638015
Havlik J and Holý M [Erythromycin stearate Spofa--coated tablets for pediatric practice]. 1976 Cesk Pediatr pmid:963828
Shimatani T Involvement of cholinergic motor neurons in pharmacological regulation of gastrointestinal motility by glucagon in conscious dogs. 1997 Aug-Oct J Smooth Muscle Res pmid:9639019
Oyarzún E et al. Antibiotic treatment in preterm labor and intact membranes: a randomized, double-blinded, placebo-controlled trial. 1998 May-Jun J Matern Fetal Med pmid:9642605
Jeffreys AJ and Craig IW Analysis of proteins synthesized in mitochondria of cultured mammalian cells. An assessment of current approaches and problems in interpretation. 1976 Eur. J. Biochem. pmid:964267
Kobashi Y et al. [A case of Listeria monocytogenes sepsis in an elderly who survived]. 1998 Kansenshogaku Zasshi pmid:9642946
Hoshino K et al. [Antimicrobial activity of macrolides against clinical isolates]. 1998 Jpn J Antibiot pmid:9644599
Nakae M et al. [Drug susceptibility of clinically isolated Helicobacter pylori]. 1998 Jpn J Antibiot pmid:9644601
Shryock TR et al. Antimicrobial susceptibility of Moraxella bovis. 1998 Vet. Microbiol. pmid:9646479
Pasco J What has the patient been taking? 1998 Aust Fam Physician pmid:9648320
Gharaibeh MN et al. Effect of multiple doses of rifampin on the [14C N-methyl] erythromycin breath test in healthy male volunteers. 1998 J Clin Pharmacol pmid:9650537
Suzuki Y et al. [Antimicrobial activities of clindamycin against clinical isolated Streptococcus pneumoniae]. 1997 Jpn J Antibiot pmid:9651606
Wehbeh HA et al. Single-dose azithromycin for Chlamydia in pregnant women. 1998 J Reprod Med pmid:9653697
O'Halloran HS et al. Leber's neuroretinitis in a patient with serologic evidence of Bartonella elizabethae. 1998 Retina (Philadelphia, Pa.) pmid:9654422
Orden B et al. Erythromycin resistance of Streptococcus pyogenes in Madrid. 1998 Pediatr. Infect. Dis. J. pmid:9655536
Kuyucu N et al. Comparison of oral erythromycin, local administration of streptomycin and placebo therapy for nonsuppurative Bacillus Calmette-Guérin lymphadenitis. 1998 Pediatr. Infect. Dis. J. pmid:9655549
Rangel-Lugo M et al. Prevention of antibiotic residues in veal calves fed colostrum. 1998 J. Am. Vet. Med. Assoc. pmid:9656021
[Streptococcus pyogenes and resistance to macrolides: experience at Monza]. 1998 Jan-Feb Minerva Pediatr. pmid:9658791
Azuma A et al. Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats. 1998 Thorax pmid:9659353
Schultz MJ et al. Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood. 1998 Antimicrob. Agents Chemother. pmid:9660992
Kadota J et al. Inhibitory effect of erythromycin on superoxide anion production by human neutrophils primed with granulocyte-colony stimulating factor. 1998 Antimicrob. Agents Chemother. pmid:9661038
D'Souza P et al. A comparative study of therapeutic response of patients with clinical chancroid to ciprofloxacin, erythromycin, and cotrimoxazole. 1998 Sex Transm Dis pmid:9662762
Gamaleia NB and Levashev VS [Biological properties and mechanisms of development of bacteria resistant to fusidin, erythromycin and chloramphenicol]. 1978 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:96638
Verhagen MA et al. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. 1997 Aliment. Pharmacol. Ther. pmid:9663833
Griffin RG Dipolar recoupling in MAS spectra of biological solids. 1998 Nat. Struct. Biol. pmid:9665180
Yagi Y et al. Characterization of a small plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain of Streptococcus sanguis isolated from dental plaque. 1978 Antimicrob. Agents Chemother. pmid:96738
As incidence increases CDC recommends 1976 treatment schedule for syphilis. 1976 Pa Med pmid:967481
Rathgeber J and Burchardi H [Use of the antibiotic erythromycin in intestinal motility disorders]. 1998 Anaesthesist pmid:9676314
Hayakawa H et al. Diffuse panbronchiolitis and rheumatoid arthritis-associated bronchiolar disease: similarities and differences. 1998 Intern. Med. pmid:9678682
Enomoto F et al. [Evaluation of methods of macrolide antibiotic administration in experimental otitis media of rats]. 1997 Jpn J Antibiot pmid:9678980
Ikeda K et al. [Effect of macrolide antibiotics on ion transport of nasal mucosal epithelium]. 1997 Jpn J Antibiot pmid:9678982
Wessel F [Peri-anesthesia allergies to antibiotics]. 1998 Allerg Immunol (Paris) pmid:9684043
Stassi D et al. A genetically engineered strain of Saccharopolyspora erythraea that produces 6,12-dideoxyerythromycin A as the major fermentation product. 1998 Appl. Microbiol. Biotechnol. pmid:9684306
Tripathi S et al. Ketolide resistance conferred by short peptides. 1998 J. Biol. Chem. pmid:9685347
Bowman ED et al. Impact of erythromycin on respiratory colonization of Ureaplasma urealyticum and the development of chronic lung disease in extremely low birth weight infants. 1998 Pediatr. Infect. Dis. J. pmid:9686728
Hamilton-Miller JM and Shah S Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status. 1998 J. Antimicrob. Chemother. pmid:9687104
Gaudreau C and Gilbert H Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada. 1998 Antimicrob. Agents Chemother. pmid:9687415
Petrakis J et al. Enhancement of gastric emptying of solids by erythromycin in patients with Roux-en-Y gastrojejunostomy. 1998 Arch Surg pmid:9687997
Ehrenpreis ED et al. Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. 1998 Aliment. Pharmacol. Ther. pmid:9690728
Staunton J Combinatorial biosynthesis of erythromycin and complex polyketides. 1998 Curr Opin Chem Biol pmid:9691072
Kanfer I et al. Analysis of macrolide antibiotics. 1998 J Chromatogr A pmid:9691324
Segura-Corrales J et al. [Cat-scratch disease. Presentation of 2 cases in a family with serologic follow-up and discussion of diagnostic methods]. 1998 Rev Clin Esp pmid:9691742
Weissman KJ et al. Origin of starter units for erythromycin biosynthesis. 1998 Biochemistry pmid:9692995
Milla E et al. Bilateral optic papillitis following mycoplasma pneumoniae pneumonia. 1998 Ophthalmologica pmid:9693295